Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: What is happening in the schizophrenic brain?

Archives of General Psychiatry

Volumn 59, Issue 6, 2002, Pages 553-558

  Weinberger, Daniel R ^a   McClure, Robert K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; JET LAG; MEASUREMENT; MORPHOMETRICS; NERVE CELL PLASTICITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCHIZOPHRENIA; STRESS;

EID: 0036277310     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.6.553     Document Type: Review

References (75)

1. Implications of normal brain development for the pathogenesis of schizophrenia
2. The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave
3. A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia
4. Stability of CT scan findings in schizophrenia: Results of an 8 year follow-up study
5. Brain morphology in schizophrenia: A 2- to 5-year CT scan follow-up study
6. Three-year follow-up of older schizophrenics: Extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio
7. Cerebral ventricular enlargement in schizophreniform disorder does not progress: A seven year follow-up study
8. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia
9. Ventricle-to-brain ratio in schizophrenia: A controlled follow-up study
10. Schizophrenia as a progressive disorder: Relations to EEG, CT, neuropathological and other evidence
11. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?
12. Is schizophrenia a progressive neurodevelopmental disorder? toward a unitary pathogenetic mechanism
13. Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
14. Glutamate receptor dysfunction and schizophrenia
15. The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
16. Hippocampal volume reduction in major depression
17. Does stress damage the brain?
18. Stress, adaptation, and disease: Allostasis and allostatic load
19. Chronic "jet lag" produces temporal lobe atrophy and spatial cognitive deficits
20. A molecular and cellular theory of depression
21. Long-term potentiation: A decade of progress?
22. More hippocampal neurons in adult mice living in an enriched environment
23. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
24. Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study
25. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical dissectors
26. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method
27. The neuropathology of schizophrenia: A critical review of the data and their interpretation
28. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (N MBA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex
29. Reactive gliosis of immature Bergmann glia and microglial cell activation in response to cell death of granule cell precursors induced by methylazoxymethanol treatment in developing rat cerebellum
30. Epilepsy
31. Kainate-induced apoptotic cell death in hippocampal neurons
32. DNA fragmentation in rat brain after intraperitoneal administration of kainate
33. Apoptosis in the aging process
34. Apoptosis and gene expression: Perspectives on alcohol-induced brain damage
35. Brain atrophy and neuronal loss in alcoholism: A role for DNA damage?
36. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: Implications for mood disorders
37. Apoptosis and Alzheimer's disease
38. Kainate-induced genes in the hippocampus: Lessons from expression patterns
39. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging
40. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice
41. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice
42. N-myc and c-myc expression in Alzheimer's disease, Huntington disease and Parkinson disease
43. Cell biology of the hippocampal formation in schizophrenia
44. The Bcl-2 protein family: Arbiters of cell survival
45. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia
46. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia
47. A review of longitudinal studies of cognitive functions in schizophrenia patients
48. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder
49. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings
50. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
51. Association of brain structural change with heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization
52. Childhood-onset schizophrenia: Progressive ventricular change during adolescence
53. Progression of cerebro-ventricular enlargement and the subtyping of schizophrenia
54. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia
55. A follow-up magnetic resonance imaging study of schizophrenia: Relationship of neuroanatomical changes to clinical and neurobehavioral measures
56. Ventricular enlargement in poor-outcome schizophrenia
57. Brain and ventricular instability during psychotic episodes of the schizophrenias
58. Longitudinal study of brain morphology in first episode schizophrenia
59. Hippocampus in Alzheimer's disease: A 3-year follow-up MRI study
60. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type
61. Detection of subtle brain changes using subvoxel registration and subtraction of serial MR images
62. Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid
63. Reversible brain shrinkage in abstinent alcoholics, measured by MRI
64. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics
65. Apparent cerebral atrophy in patients on treatment with steroids
66. The identification of cerebral volume changes in treated growth hormone-deficient adults using serial 3D MR image processing
67. Lithium-induced increase in human brain grey matter
68. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine
69. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics
70. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking anti-psychotic drugs
71. Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
72. Hippocampal damage associated with prolonged glucocorticoid exposure in primates
73. Quantitative MRI hippocampal volumes: Association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients
74. Atrophy of mesial structures in patients with temporal lobe epilepsy: Cause or consequence of repeated seizures?
75. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy